<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>240720</rcn>
  <id>190141418</id>
  <acronym>ATLAS</acronym>
  <teaser>ATLAS is a powerful in silico drug discovery platform leveraging the latest advances in high-performance and quantum computing. The platform is the result of decades of research by leading experts in molecular dynamics. The technology is grounded on over 100 peer-reviewed...</teaser>
  <objective>ATLAS is a powerful in silico drug discovery platform leveraging the latest advances in high-performance and quantum computing. The platform is the result of decades of research by leading experts in molecular dynamics. The technology is grounded on over 100 peer-reviewed papers and two ERC grants. Our beta code has gathered important accolades like the prestigious ATOS-Joseph Fourier prize and first place at the foremost rational drug design competitionthe SAMPL challenge.
 
ATLAS can replace costly and laborious experiments. It can even run entire drug discovery campaigns in silico, reducing cycle times and cost by at least 50%. By 2027, we will have a 35-project portfolio, and the first ATLAS-generated compound will reach the clinic. Thereafter, our objective is to generate a new candidate every 18 months. That year, our team will surpass 50 people and well expand into the US market. We aim at securing a leadership position in the nascent in-silico drug discovery market.</objective>
  <title>Next generation HPC/QC in silico drug discovery platform for de novo design</title>
  <totalCost>4249375</totalCost>
  <ecMaxContribution>2500000</ecMaxContribution>
  <startDate>2022-09-01</startDate>
  <endDate>2024-08-31</endDate>
  <ecSignatureDate>2022-07-28</ecSignatureDate>
  <duration>24</duration>
  <status>CLOSED</status>
  <keywords>Drug discovery,molecular dynamics,quantum physics</keywords>
  <identifiers>
    <grantDoi>10.3030/190141418</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2022-07-31 20:55:35</sourceUpdateDate>
  <contentCreationDate>2022-09-04 12:36:12</contentCreationDate>
  <contentUpdateDate>2022-09-04 12:35:47</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:45</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>437862</rcn>
        <id>437862-drug-discovery-goes-quantum</id>
        <title>Drug discovery goes quantum</title>
        <contentUpdateDate>2022-12-07 17:34:03</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode>/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55402</rcn>
        <title>HORIZON-EIC-2021-ACCELERATORCHALLENGES-01</title>
        <identifier>HORIZON-EIC-2021-ACCELERATORCHALLENGES-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55402</rcn>
        <title>HORIZON-EIC-2021-ACCELERATORCHALLENGES-01</title>
        <identifier>HORIZON-EIC-2021-ACCELERATORCHALLENGES-01</identifier>
      </call>
      <organization netEcContribution="2500000" totalCost="4249375" source="corda" order="1" ecContribution="2500000" terminated="false" sme="true" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1976495</rcn>
        <id>895078559</id>
        <vatNumber>FR00883649238</vatNumber>
        <legalName>QUBIT PHARMACEUTICALS</legalName>
        <shortName>QUBIT</shortName>
        <address>
          <street>24 RUE DU FAUBOURG SAINT-JACQUES</street>
          <city>Paris</city>
          <postalCode>75014</postalCode>
          <country>FR</country>
          <geolocation>48.8374635,2.3385229</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Paris</name>
              <rcn>258740225</rcn>
              <nutsCode>FR101</nutsCode>
              <parents>
                <region>
                  <name>Ile-de-France</name>
                  <rcn>258740264</rcn>
                  <nutsCode>FR10</nutsCode>
                  <parents>
                    <region>
                      <name>Ile-de-France</name>
                      <rcn>258742824</rcn>
                      <nutsCode>FR1</nutsCode>
                      <parents>
                        <region>
                          <name>France</name>
                          <rcn>258902568</rcn>
                          <nutsCode>FR</nutsCode>
                          <euCode>FR</euCode>
                          <isoCode>FR</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>France</name>
              <rcn>258902568</rcn>
              <nutsCode>FR</nutsCode>
              <euCode>FR</euCode>
              <isoCode>FR</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>706027</rcn>
        <id>HORIZON_HORIZON-EIC-2021-ACCELERATORCHALLENGES-01-01</id>
        <code>HORIZON-EIC-2021-ACCELERATORCHALLENGES-01-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Strategic Digital and Health Technologies</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456234</code>
              <title>Project financing</title>
              <displayCode>/Project financing</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453711</code>
              <title>Intensive care</title>
              <displayCode>/Intensive care</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454386</code>
              <title>Market-creating innovation</title>
              <displayCode>/Market-creating innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450539</code>
              <title>Competitor analysis</title>
              <displayCode>/Competitor analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451019</code>
              <title>Diagnostic tools (e.g. genetic, imaging)</title>
              <displayCode>/Diagnostic tools (e.g. genetic, imaging)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42849482</code>
              <title>Cloud, Edge and Virtualisation</title>
              <displayCode>/Cloud, Edge and Virtualisation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450029</code>
              <title>Business model innovation</title>
              <displayCode>/Business model innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451698</code>
              <title>Entrepreneurship</title>
              <displayCode>/Entrepreneurship</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453594</code>
              <title>Innovation support services</title>
              <displayCode>/Innovation support services</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453006</code>
              <title>Healthcare system</title>
              <displayCode>/Healthcare system</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43457773</code>
              <title>Spin-off companies</title>
              <displayCode>/Spin-off companies</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456213</code>
              <title>Product innovation</title>
              <displayCode>/Product innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454395</code>
              <title>Marketing strategy</title>
              <displayCode>/Marketing strategy</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453822</code>
              <title>Investment readiness</title>
              <displayCode>/Investment readiness</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42849506</code>
              <title>High-performance computing (HPC)</title>
              <displayCode>/High-performance computing (HPC)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42849476</code>
              <title>Artificial intelligence</title>
              <displayCode>/Artificial intelligence</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450317</code>
              <title>Clinical management</title>
              <displayCode>/Clinical management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458169</code>
              <title>Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)</title>
              <displayCode>/Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452043</code>
              <title>Feasibility analysis</title>
              <displayCode>/Feasibility analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42849512</code>
              <title>Industrial IoT and Control Systems (e.g. SCADA and Cyber Physical Systems – CPS)</title>
              <displayCode>/Industrial IoT and Control Systems (e.g. SCADA and Cyber Physical Systems – CPS)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42849503</code>
              <title>Hardware technology (RFID, chips, sensors, networking, etc.)</title>
              <displayCode>/Hardware technology (RFID, chips, sensors, networking, etc.)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458031</code>
              <title>Sustainable innovation</title>
              <displayCode>/Sustainable innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458994</code>
              <title>Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation</title>
              <displayCode>/Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451013</code>
              <title>Diagnostic and implantable devices, environmental monitoring</title>
              <displayCode>/Diagnostic and implantable devices, environmental monitoring</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450041</code>
              <title>Business support services</title>
              <displayCode>/Business support services</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458163</code>
              <title>Technological innovation</title>
              <displayCode>/Technological innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43457365</code>
              <title>SME support</title>
              <displayCode>/SME support</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42849521</code>
              <title>Quantum Technologies (e.g. computing and communication)</title>
              <displayCode>/Quantum Technologies (e.g. computing and communication)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456414</code>
              <title>Public sector innovation</title>
              <displayCode>/Public sector innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456186</code>
              <title>Private investment</title>
              <displayCode>/Private investment</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453576</code>
              <title>Innovation management</title>
              <displayCode>/Innovation management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450521</code>
              <title>Company valuation</title>
              <displayCode>/Company valuation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42849479</code>
              <title>Blockchain and Distributed Ledger Technology (DLT)</title>
              <displayCode>/Blockchain and Distributed Ledger Technology (DLT)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452100</code>
              <title>Financial &amp; Investment management</title>
              <displayCode>/Financial &amp; Investment management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451181</code>
              <title>Due diligence</title>
              <displayCode>/Due diligence</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42848957</code>
              <title>Cybersecurity Domains</title>
              <displayCode>/Cybersecurity Domains</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450761</code>
              <title>Critical care medicine and Emergency medicine</title>
              <displayCode>/Critical care medicine and Emergency medicine</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458202</code>
              <title>Technology management</title>
              <displayCode>/Technology management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450026</code>
              <title>Business management</title>
              <displayCode>/Business management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450017</code>
              <title>Business development</title>
              <displayCode>/Business development</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452667</code>
              <title>Gene therapy, cell therapy, regenerative medicine</title>
              <displayCode>/Gene therapy, cell therapy, regenerative medicine</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454512</code>
              <title>Medical engineering and technology</title>
              <displayCode>/Medical engineering and technology</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/31101580</code>
              <title>Health</title>
              <displayCode>/Health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43457812</code>
              <title>Start-up companies</title>
              <displayCode>/Start-up companies</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458661</code>
              <title>Venture capital</title>
              <displayCode>/Venture capital</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458190</code>
              <title>Technology commercialisation</title>
              <displayCode>/Technology commercialisation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454509</code>
              <title>Medical engineering</title>
              <displayCode>/Medical engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450014</code>
              <title>Business coaching and mentoring</title>
              <displayCode>/Business coaching and mentoring</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452952</code>
              <title>Health care sciences and services (including hospital administration, health care financing)</title>
              <displayCode>/Health care sciences and services (including hospital administration, health care financing)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43455337</code>
              <title>Oncology</title>
              <displayCode>/Oncology</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43449852</code>
              <title>Biomarkers</title>
              <displayCode>/Biomarkers</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451452</code>
              <title>Electronic patient files</title>
              <displayCode>/Electronic patient files</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42849515</code>
              <title>Internet of Things, embedded systems, pervasive systems</title>
              <displayCode>/Internet of Things, embedded systems, pervasive systems</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456756</code>
              <title>Risk management</title>
              <displayCode>/Risk management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42849305</code>
              <title>Software and Hardware Security Engineering</title>
              <displayCode>/Software and Hardware Security Engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453837</code>
              <title>IPR management</title>
              <displayCode>/IPR management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451022</code>
              <title>Diagnostics</title>
              <displayCode>/Diagnostics</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454506</code>
              <title>Medical devices</title>
              <displayCode>/Medical devices</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedLegalBasis" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>705794</rcn>
        <id>HORIZON.3.1.2</id>
        <code>HORIZON.3.1.2</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1.2</pga>
        <title>The Accelerator</title>
        <parent>
          <programme>
            <rcn>705792</rcn>
            <code>HORIZON.3.1</code>
            <parent>
              <programme>
                <rcn>705791</rcn>
                <code>HORIZON.3</code>
                <parent>
                  <programme>
                    <rcn>705725</rcn>
                    <code>HORIZON</code>
                  </programme>
                </parent>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237683</rcn>
        <id>190141418_F529FFA56A757914E20AE63C65B90485_IPRHORIZON</id>
        <title>Method for generating overlap-guided compact ansatz for practical quantum chemistry, uses thereof and related computing systems</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>305081.4</iprNumber>
          <iprDate>2024-01-23</iprDate>
          <iprPrefix>EP23</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1976495</rcn>
              <id>895078559</id>
              <vatNumber>FR00883649238</vatNumber>
              <legalName>QUBIT PHARMACEUTICALS</legalName>
              <shortName>QUBIT</shortName>
              <address>
                <street>24 RUE DU FAUBOURG SAINT-JACQUES</street>
                <city>Paris</city>
                <postalCode>75014</postalCode>
                <country>FR</country>
                <geolocation>48.8374635,2.3385229</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Paris</name>
                    <rcn>258740225</rcn>
                    <nutsCode>FR101</nutsCode>
                    <parents>
                      <region>
                        <name>Ile-de-France</name>
                        <rcn>258740264</rcn>
                        <nutsCode>FR10</nutsCode>
                        <parents>
                          <region>
                            <name>Ile-de-France</name>
                            <rcn>258742824</rcn>
                            <nutsCode>FR1</nutsCode>
                            <parents>
                              <region>
                                <name>France</name>
                                <rcn>258902568</rcn>
                                <nutsCode>FR</nutsCode>
                                <euCode>FR</euCode>
                                <isoCode>FR</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>France</name>
                    <rcn>258902568</rcn>
                    <nutsCode>FR</nutsCode>
                    <euCode>FR</euCode>
                    <isoCode>FR</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/OTHER</code>
              <title>Other</title>
              <displayCode>/Other</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237680</rcn>
        <id>190141418_F530CC5E9C443E0AFB13984D6EE33C69_IPRHORIZON</id>
        <title>Methods and systems for polylogarithmic-depth controlled-NOT gate implementation in quantum circuits and computers</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>307297.4</iprNumber>
          <iprDate>2023-12-20</iprDate>
          <iprPrefix>EP23</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1976495</rcn>
              <id>895078559</id>
              <vatNumber>FR00883649238</vatNumber>
              <legalName>QUBIT PHARMACEUTICALS</legalName>
              <shortName>QUBIT</shortName>
              <address>
                <street>24 RUE DU FAUBOURG SAINT-JACQUES</street>
                <city>Paris</city>
                <postalCode>75014</postalCode>
                <country>FR</country>
                <geolocation>48.8374635,2.3385229</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Paris</name>
                    <rcn>258740225</rcn>
                    <nutsCode>FR101</nutsCode>
                    <parents>
                      <region>
                        <name>Ile-de-France</name>
                        <rcn>258740264</rcn>
                        <nutsCode>FR10</nutsCode>
                        <parents>
                          <region>
                            <name>Ile-de-France</name>
                            <rcn>258742824</rcn>
                            <nutsCode>FR1</nutsCode>
                            <parents>
                              <region>
                                <name>France</name>
                                <rcn>258902568</rcn>
                                <nutsCode>FR</nutsCode>
                                <euCode>FR</euCode>
                                <isoCode>FR</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>France</name>
                    <rcn>258902568</rcn>
                    <nutsCode>FR</nutsCode>
                    <euCode>FR</euCode>
                    <isoCode>FR</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/OTHER</code>
              <title>Other</title>
              <displayCode>/Other</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1071600</rcn>
        <id>190141418_PSHORIZON</id>
        <title>Periodic Reporting for period 2 - ATLAS (Next generation HPC/QC in silico drug discovery platform for de novo design)</title>
        <description>periodic</description>
        <teaser>Drug Discovery is a long &amp; costly process currently mostly driven by wet lab experiments. The reason, simulations tools did not achieve the same reliability and performance than in the aerospace, automotive or engineering sectors. This is exactly what the Atlas project aims to...</teaser>
        <sourceUpdateDate>2024-12-18 16:03:19</sourceUpdateDate>
        <contentUpdateDate>2024-12-18 16:03:19</contentUpdateDate>
        <relations>
          <associations>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/annual-qubit-pharma-meeting-full-team.png</uri>
              <alternativeText>Annual Qubit Pharma meeting, full team</alternativeText>
              <mimetype>image/png</mimetype>
              <size>936960</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/high-resolution-ball-representation-of-hiv-1-protease.png</uri>
              <alternativeText>High resolution ball representation of HIV-1 protease</alternativeText>
              <mimetype>image/png</mimetype>
              <size>287744</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/press-conference2024.png</uri>
              <alternativeText>"Press conference on advancements in quantum algorithms for drug discovery at Qubit HQ, July2024</alternativeText>
              <mimetype>image/png</mimetype>
              <size>324608</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/ministers-hq.jpg</uri>
              <alternativeText>Roland Lescure, Industry Minister; Sylvie Retailleau, Education Minister; Aruélien Rousseau at Qubit</alternativeText>
              <mimetype>image/jpeg</mimetype>
              <size>34816</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/gaia-super-computer.png</uri>
              <alternativeText>Gaia Super-computer</alternativeText>
              <mimetype>image/png</mimetype>
              <size>423936</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/hia.jpg</uri>
              <alternativeText>Lise Alter, Managing Director of the Health Innovation Agency, visited Qubit Pharma HQ, Oct 12 2023</alternativeText>
              <mimetype>image/jpeg</mimetype>
              <size>35840</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/qatar.jpg</uri>
              <alternativeText>Part of the delegation accompanying French Economy Minister Bruno Le Maire to the Middle East, 2024</alternativeText>
              <mimetype>image/jpeg</mimetype>
              <size>67584</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/bio-international2024.png</uri>
              <alternativeText>BIO International 2024 convention, San Diego, USA - 6th June 2024</alternativeText>
              <mimetype>image/png</mimetype>
              <size>1020928</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/vtx-high-resolution-ses-path-tracking.png</uri>
              <alternativeText>VTX high resolution SES path tracking</alternativeText>
              <mimetype>image/png</mimetype>
              <size>396288</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/hpc-team-in-front-of-our-gpu-super-computer-gaia.png</uri>
              <alternativeText>HPC team in front of our GPU super-computer Gaia</alternativeText>
              <mimetype>image/png</mimetype>
              <size>649216</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/solvent-excluded-surface-ses-high-resolution-image-from-vtx.png</uri>
              <alternativeText>Solvent excluded Surface (SES) high resolution image from VTX</alternativeText>
              <mimetype>image/png</mimetype>
              <size>343040</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/bio-europe2023.png</uri>
              <alternativeText>Marion Pierfitte, COO, and Jean-Baptiste Bouin, Project Manager, at BIO Europe, Munich, Nov 6-8,2023</alternativeText>
              <mimetype>image/png</mimetype>
              <size>70656</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/coo-wef.png</uri>
              <alternativeText>COO Marion Pierfitte, part of French startups delegation accompanying President Macron to WEF2024</alternativeText>
              <mimetype>image/png</mimetype>
              <size>134144</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/uae.png</uri>
              <alternativeText>Part of the delegation accompanying French Economy Minister Bruno Le Maire to Abu Dhabi, UAE, 2024</alternativeText>
              <mimetype>image/png</mimetype>
              <size>956416</size>
            </webItem>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/190141/190141418_PS/quantum-italia.png</uri>
              <alternativeText>CEO speaking at Quantum Italia conference on 'Quantum Tech &amp; Pharma Research,' Rome, 28 June 2024</alternativeText>
              <mimetype>image/png</mimetype>
              <size>578560</size>
            </webItem>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode>/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237686</rcn>
        <id>190141418_9F919D4F661E177D74DFF2E3F8C768FC_IPRHORIZON</id>
        <title>Method for generating optimized ansatz with adaptive variational quantum algorithms on a noisy intermediate scale quantum computer for example for practical quantum chemistry, uses thereof and related computing systems</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>306077.1</iprNumber>
          <iprDate>2023-06-29</iprDate>
          <iprPrefix>EP23</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1976495</rcn>
              <id>895078559</id>
              <vatNumber>FR00883649238</vatNumber>
              <legalName>QUBIT PHARMACEUTICALS</legalName>
              <shortName>QUBIT</shortName>
              <address>
                <street>24 RUE DU FAUBOURG SAINT-JACQUES</street>
                <city>Paris</city>
                <postalCode>75014</postalCode>
                <country>FR</country>
                <geolocation>48.8374635,2.3385229</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Paris</name>
                    <rcn>258740225</rcn>
                    <nutsCode>FR101</nutsCode>
                    <parents>
                      <region>
                        <name>Ile-de-France</name>
                        <rcn>258740264</rcn>
                        <nutsCode>FR10</nutsCode>
                        <parents>
                          <region>
                            <name>Ile-de-France</name>
                            <rcn>258742824</rcn>
                            <nutsCode>FR1</nutsCode>
                            <parents>
                              <region>
                                <name>France</name>
                                <rcn>258902568</rcn>
                                <nutsCode>FR</nutsCode>
                                <euCode>FR</euCode>
                                <isoCode>FR</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>France</name>
                    <rcn>258902568</rcn>
                    <nutsCode>FR</nutsCode>
                    <euCode>FR</euCode>
                    <isoCode>FR</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/OTHER</code>
              <title>Other</title>
              <displayCode>/Other</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237682</rcn>
        <id>190141418_B64AE5D59C7E454B6B07A31AC1968FF5_IPRHORIZON</id>
        <title>Trademark Qubit Pharmaceuticals</title>
        <details>
          <iprAwarded>FR</iprAwarded>
          <iprNumber>23/5001274</iprNumber>
          <iprDate>2023-10-25</iprDate>
          <iprPrefix>France-</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1976495</rcn>
              <id>895078559</id>
              <vatNumber>FR00883649238</vatNumber>
              <legalName>QUBIT PHARMACEUTICALS</legalName>
              <shortName>QUBIT</shortName>
              <address>
                <street>24 RUE DU FAUBOURG SAINT-JACQUES</street>
                <city>Paris</city>
                <postalCode>75014</postalCode>
                <country>FR</country>
                <geolocation>48.8374635,2.3385229</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Paris</name>
                    <rcn>258740225</rcn>
                    <nutsCode>FR101</nutsCode>
                    <parents>
                      <region>
                        <name>Ile-de-France</name>
                        <rcn>258740264</rcn>
                        <nutsCode>FR10</nutsCode>
                        <parents>
                          <region>
                            <name>Ile-de-France</name>
                            <rcn>258742824</rcn>
                            <nutsCode>FR1</nutsCode>
                            <parents>
                              <region>
                                <name>France</name>
                                <rcn>258902568</rcn>
                                <nutsCode>FR</nutsCode>
                                <euCode>FR</euCode>
                                <isoCode>FR</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>France</name>
                    <rcn>258902568</rcn>
                    <nutsCode>FR</nutsCode>
                    <euCode>FR</euCode>
                    <isoCode>FR</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/TRADEMARK</code>
              <title>Trademark</title>
              <displayCode>/Trademark</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237675</rcn>
        <id>190141418_057658AB58DC7570B1E3DFE45B55FF2F_IPRHORIZON</id>
        <title>Computer implemented method for computing quantum-enhanced chemical properties of a chemical system</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>305780.9</iprNumber>
          <iprDate>2024-05-17</iprDate>
          <iprPrefix>EP24</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1976495</rcn>
              <id>895078559</id>
              <vatNumber>FR00883649238</vatNumber>
              <legalName>QUBIT PHARMACEUTICALS</legalName>
              <shortName>QUBIT</shortName>
              <address>
                <street>24 RUE DU FAUBOURG SAINT-JACQUES</street>
                <city>Paris</city>
                <postalCode>75014</postalCode>
                <country>FR</country>
                <geolocation>48.8374635,2.3385229</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Paris</name>
                    <rcn>258740225</rcn>
                    <nutsCode>FR101</nutsCode>
                    <parents>
                      <region>
                        <name>Ile-de-France</name>
                        <rcn>258740264</rcn>
                        <nutsCode>FR10</nutsCode>
                        <parents>
                          <region>
                            <name>Ile-de-France</name>
                            <rcn>258742824</rcn>
                            <nutsCode>FR1</nutsCode>
                            <parents>
                              <region>
                                <name>France</name>
                                <rcn>258902568</rcn>
                                <nutsCode>FR</nutsCode>
                                <euCode>FR</euCode>
                                <isoCode>FR</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>France</name>
                    <rcn>258902568</rcn>
                    <nutsCode>FR</nutsCode>
                    <euCode>FR</euCode>
                    <isoCode>FR</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/OTHER</code>
              <title>Other</title>
              <displayCode>/Other</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237671</rcn>
        <id>190141418_ADA184B3CEB6380BB303F3E9636A72E2_IPRHORIZON</id>
        <title>Methods and systems for adjustable-depth circuit ofr controlled-NOT gate implementation in quantum circuits and computers and controlled-NOT gate thereof</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>307298.2</iprNumber>
          <iprDate>2023-12-20</iprDate>
          <iprPrefix>EP23</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1976495</rcn>
              <id>895078559</id>
              <vatNumber>FR00883649238</vatNumber>
              <legalName>QUBIT PHARMACEUTICALS</legalName>
              <shortName>QUBIT</shortName>
              <address>
                <street>24 RUE DU FAUBOURG SAINT-JACQUES</street>
                <city>Paris</city>
                <postalCode>75014</postalCode>
                <country>FR</country>
                <geolocation>48.8374635,2.3385229</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Paris</name>
                    <rcn>258740225</rcn>
                    <nutsCode>FR101</nutsCode>
                    <parents>
                      <region>
                        <name>Ile-de-France</name>
                        <rcn>258740264</rcn>
                        <nutsCode>FR10</nutsCode>
                        <parents>
                          <region>
                            <name>Ile-de-France</name>
                            <rcn>258742824</rcn>
                            <nutsCode>FR1</nutsCode>
                            <parents>
                              <region>
                                <name>France</name>
                                <rcn>258902568</rcn>
                                <nutsCode>FR</nutsCode>
                                <euCode>FR</euCode>
                                <isoCode>FR</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>France</name>
                    <rcn>258902568</rcn>
                    <nutsCode>FR</nutsCode>
                    <euCode>FR</euCode>
                    <isoCode>FR</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/OTHER</code>
              <title>Other</title>
              <displayCode>/Other</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237672</rcn>
        <id>190141418_74E8D51745CEE8396A7C7145ECD443E8_IPRHORIZON</id>
        <title>Approximating a density function based on a Gaussian mixture using aquantum computer</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>305613.4</iprNumber>
          <iprDate>2023-04-20</iprDate>
          <iprPrefix>EP23</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1976495</rcn>
              <id>895078559</id>
              <vatNumber>FR00883649238</vatNumber>
              <legalName>QUBIT PHARMACEUTICALS</legalName>
              <shortName>QUBIT</shortName>
              <address>
                <street>24 RUE DU FAUBOURG SAINT-JACQUES</street>
                <city>Paris</city>
                <postalCode>75014</postalCode>
                <country>FR</country>
                <geolocation>48.8374635,2.3385229</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Paris</name>
                    <rcn>258740225</rcn>
                    <nutsCode>FR101</nutsCode>
                    <parents>
                      <region>
                        <name>Ile-de-France</name>
                        <rcn>258740264</rcn>
                        <nutsCode>FR10</nutsCode>
                        <parents>
                          <region>
                            <name>Ile-de-France</name>
                            <rcn>258742824</rcn>
                            <nutsCode>FR1</nutsCode>
                            <parents>
                              <region>
                                <name>France</name>
                                <rcn>258902568</rcn>
                                <nutsCode>FR</nutsCode>
                                <euCode>FR</euCode>
                                <isoCode>FR</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>France</name>
                    <rcn>258902568</rcn>
                    <nutsCode>FR</nutsCode>
                    <euCode>FR</euCode>
                    <isoCode>FR</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/OTHER</code>
              <title>Other</title>
              <displayCode>/Other</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-EIC-ACC-BF</code>
        <title>HORIZON EIC Accelerator Blended Finance</title>
        <description>HORIZON EIC Accelerator Blended Finance</description>
        <displayCode>/HORIZON EIC Accelerator Blended Finance</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>